Society Of Interventional Radiology Supports Treatment For Painful Spine Fractures: Patient Selection Key
Given the current controversy over vertebroplasty -- a minimally invasive treatment performed by interventional radiologists in individuals with painful osteoporotic vertebral compression fractures that fail to respond to conventional medical therapy -- what's a patient to do? Trust your medical team to decide if you are an appropriate candidate for vertebroplasty and trust the experience of hundreds of thousands of other patients who have undergone the spine treatment successfully and received life-improving effects, says the Society of Interventional Radiology. "Hundreds of thousands of patients have greatly benefited from vertebroplasty with almost complete resolution of their pain;
Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company (NYSE: KCI), announced the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1, 500 patients.
Paget's disease of bone, often just called Paget's disease or osteitis deformans, is a condition in which the normal cycle of bone growth is disrupted. The condition affects bone metabolism that allows for old bone to be recycled into new bone throughout life. This can cause bones to become weakened and deformed. In Paget's disease of bone, the rate at which old bone is broken down and new bone is formed is altered. Over time, it may result in bones becoming fragile. Common symptoms of Paget's disease include bone pain and deformity. The disease is named after Sir James Paget, the British surgeon who first described it in 1877. According to Medilexicon's medical dictionary: PagetĀ s disease of bone is "a generalized skeletal disease, frequently familial, of older people in which bone resorption and formation are both increased, leading to thickening and softening of bones (the skull), and bending of weight-bearing bones.
Since the beginning of Operations Iraqi Freedom and Enduring Freedom, there have been nearly 36, 000 battle- injured warriors, of which approximately 82 percent suffer extremity trauma. Many of these injuries are complicated by the effects of improvised explosive devices which cause injury patterns distinct from civilian trauma. Traditional wound-management guidelines simply fall short. In an effort to address the increasing number and severity of extremity war injuries among the nation's warriors serving in Iraq and Afghanistan, the American Academy of Orthopaedic Surgeons (AAOS), the Society of Military Orthopaedic Surgeons (SOMOS), the Orthopaedic Trauma Association (OTA), and the Orthopaedic Research Society (ORS) will bring together the nation's top civilian and military orthopaedic trauma surgeons and researchers for a two-day symposium January 27 - 29 to discuss barriers of return of function and duty and develop treatment principles.
An award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will aid a partnership between the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center in finding new ways to use adult stem cells to speed repair of musculoskeletal soft tissue injuries. The five-year grant is for $3.75 million and involves collaboration between UC's Department of Biomedical Engineering and the Division of Developmental Biology at Cincinnati Children's. David Butler, PhD, UC professor of biomedical engineering, says the award is designated as a Bioengineering Research Partnership (BRP) to support a multidisciplinary research team applying an integrative approach to solving a major biomedical problem.
Life Spine R Announces FDA Clearance Of DYNA-LINK R Spinal System And PRESIDIO TM Spinal Plating System
Life Spine announced that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to both the DYNA-LINK Spinal System and the PRESIDIO Spinal Plating System. The DYNA-LINK system features a next-generation stand-alone device that accommodates both fixed and variable angle screws. The PRESIDIO system is a thoracolumbar plating system that features multiple types of low-profile implants. Both offerings incorporate an innovative, zero-step locking mechanism and utilize comprehensive instrumentation designed to reduce surgical steps and intra-operative complexity. Michael S. Butler, Life Spine's president and CEO stated, "These two approvals are a testament to our commitment to rapidly achieving regulatory approval while at the same time introducing best-in-class products.